Apricus Biosciences, Inc (APRI) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


50% of 2 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 02/05/2016 1 month $1.20 $1.14 -5% 5 Active
DRKD DRKD 12/02/2015 3 months $1.10 $1.14 +3.64% 3 Active
Comments: Markets safest alternative to PDE-5 inh. and in lead position 4 next gen Secondary Hypogonadism drug
itssofluffyimgonnadie itssofluffyimgonnadie 10/22/2015 1 month $1.43 $1.13 -20.98% -20 Ended
Comments: hidden gem?
dalbu dalbu 10/20/2014 1 day $1.85 $1.56 -15.72% -15 Ended
NSTRASH NSTRASH 10/03/2014 1 Year $1.44 $1.54 +6.94% 6 Ended
Comments: Future product sales in Europe
mecosmo2 mecosmo2 03/14/2014 1 Year $2.46 $2.07 -15.85% -15 Ended
Comments: Product is ready to be launch in Europe and Canada
peter_16 peter_16 01/14/2011 3 months $3.95 $3.12 -21.01% -21 Ended
Comments: Upcoming product launch will be successful

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.